Is LSA (Morning Glory) legal in Poland?

Also known as: hawaiian baby woodrose

Legal status

Controlled through the seed plants, although the alkaloid is not named in the annexes under its own name. «ARGYREIA NERVOSA» is entry lp. 29 in group I-N of Załącznik nr 2, the narcotic annex, whose entry continues with the words for live plants or dried material, seeds, extracts and concentrates. «RIVEA CORYMBOSA» is entry lp. 173 in group I-N of Załącznik nr 2, the narcotic annex, carrying the same plant wording. A search of all three annexes for lysergic acid amide and for ergine returned nothing, so the alkaloid itself is not listed while its two common seed sources are.

Consequences if caught

Capital exposure: none. Poland has no death penalty, and the heaviest band the 2005 Act reaches for any conduct with this substance is a term of years. Possession is an offence under article 62(1) of the 2005 Act and the band there is up to three years. Where the quantity is considerable, article 62(2) sets a band of one year to ten years. In a case of lesser gravity article 62(3) provides instead for a fine, a restriction of liberty or up to one year. Article 62a lets proceedings be discontinued, even before the decision to open an investigation, where the quantity is insignificant and intended for the holder's own use and a penalty would be inexpedient. That is a power of the prosecutor and not an entitlement of the holder, so it is not decriminalisation. The practical consequence is that the seeds are the offence and an isolated alkaloid would not be, which is the reverse of the usual pattern in this list. Poland does name other lysergamides: LSD at lp. 64 of group I-P, and 1P-LSD, 1cP-LSD and ETH-LAD on the third annex. Supply offences sit apart from possession. Article 56 punishes putting such a substance on the market with a fine and six months to eight years, and article 56(3) raises that to a fine and two years to twelve years where the quantity is considerable. Article 59(1) punishes supply for gain with one year to ten years. This absence is stated as at the consolidated text of 17 June 2024, Dz.U. 2024 poz. 1139, as that text stands after the amending regulations of 30 April 2025, Dz.U. 2025 poz. 598, and of 7 July 2026, Dz.U. 2026 poz. 934, read at api.sejm.gov.pl on 21 September 2026. The power to move the list belongs to the Minister of Health, exercised by rozporządzenie under article 44f of the 2005 Act, and that does not rule out a later rozporządzenie made after the date of this reading.

If prescribed or medical

There is no authorised medicinal product with this substance in Poland, so no prescription route exists for it. Article 33(1) would permit a medical use of a group I-N narcotic, and no product containing it is marketed in Poland.

Documentation

No personal import route exists, because a listed substance may be brought in only under the licensing chapter of the 2005 Act and not on a traveller's own account. The certificate issued under article 75 of the Convention implementing the Schengen Agreement is the route for a prescribed controlled medicine and does not reach a substance for which no prescription can be written. Morning glory and Hawaiian baby woodrose seeds are the practical case, and both source plants are named at lp. 29 and lp. 173.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Poland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.